“…The most of the proposed delivery nano-systems show mechanisms of action mirror that of free curcumin, allowing an effective passive targeting on different cancer cells, including cervical (Das et al, 2010), oral (Chang et al, 2013a), prostate (Mukerjee & Vishwanatha, 2009;Sanoj Rejinold et al, 2011), breast (Sanoj Rejinold et al, 2011 cancers, osteosarcoma (Peng et al, 2014), melanoma (Mangalathillam et al, 2012), and medulloblastoma (Altunbas et al, 2011) by controlling the CUR release over time. Furthermore, in vivo studies proved that nanoparticles prepared by free radical polymerization of N-isopropylacrylamide (NIPAAm), N-vinyl-2-pyrrolidone (VP), and poly(ethylene glycol) acrylate (PEG-mA), proposed for the treatment of pancreatic cancer, show negligible toxicity in mouse model (Bisht et al, 2007), while the emulsion polymerization of butyl-cyanoacrylate in the presence of CT allows the obtainment of a CUR delivery vehicles suitable for the treatment of hepatic cancer with favorable pharmacokinetic profiles (Duan et al, 2010).…”